- Home
- MNOV vs MOB Comparison
MNOV vs MOB Comparison
Compare MNOV & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNOV | MOB |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 73.8M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNOV | MOB |
|---|---|---|
| Price | $1.34 | $5.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $7.50 | ★ $10.00 |
| AVG Volume (30 Days) | 30.2K | ★ 114.8K |
| Earning Date | 05-14-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,360,807.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $180.00 | $150.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.17 | $4.15 |
| 52 Week High | $1.96 | $11.01 |
Technical Indicators
Market Signals| Indicator | MNOV | MOB |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 55.74 |
| Support Level | $1.27 | $5.46 |
| Resistance Level | $1.45 | $6.74 |
| Average True Range (ATR) | 0.04 | 0.50 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 46.90 | 56.12 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.